Trial | NCT02260141  Report issue

Title

Treating Alzheimer's and Dementia With D-ribose

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Terminated

  • Intervention/Treatment

    d-ribose ...

  • Study Participants

    3
To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm 3 X day for 8 weeks to monitor outcomes in a pilot study.
Study Started
Sep 30
2014
Primary Completion
Oct 31
2017
Study Completion
Oct 31
2017
Last Update
May 08
2020

Dietary Supplement d-ribose

giving ribose in those with a diagnosis of Alzheimer's and/or dementia

Treatment with d-ribose Experimental

Treatment with ribose 5 gm TID

Criteria 

Inclusion Criteria:

A diagnosis of Alzheimer's and/or dementia with a Mini Mental Status Exam ( MMSE) score over 12 or being ambulatory and able to travel outside the home with assistance.
Must have a caregiver living with them.

Exclusion Criteria:

Overt and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months.
No Results Posted